DeLellisRA, LloydRV, HeitzPU, EngC, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs.Lyon, France: IARC Press;2004.
2.
Sobrinho-SimõesM, MáximoV, RochaAS. Intragenic mutations in thyroid cancer. Endocrinol Metab Clin North Am.2008; 37: 333–362.
EngC. Familial papillary thyroid cancer-many syndromes, too many genes?J Clin Endocrinol Metab.2000; 85: 1755–1757.
8.
BevanS, PalT, GreenbergCR. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab.2001; 86: 3701–3704.
9.
LesueurF, StarkM, ToccoT. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab.1999; 84: 2157–2162.
10.
CanzianF, AmatiP, HarachHR. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet.1998; 63: 1743–1748.
11.
CharkesND. On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid.2006; 16: 181–186.
12.
TriponezF, WongM, SturgeonC. Does familial nonmedullary thyroid cancer adversely affect survival?. World J Surg.2006; 30: 787–793.
13.
MalchoffCD, MalchoffDM. Familial nonmedullary thyroid carcinoma. Cancer Control.2006; 13: 106–110.
14.
BakhshA, KirovG, GregoryJW, WilliamsED, LudgateM. A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer. Endocr Relat Cancer.2006; 13: 475–483.
15.
RobinsonDW, OrrTG. Carcinoma of the thyroid and other diseases of the thyroid in identical twins. AMA Arch Surg.1955; 70: 923–928.
16.
UchinoS, NoguchiS, KawamotoH. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg.2002; 26: 897–902.
17.
AlsaneaO, WadaN, AinK. Is familial nonmedullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery.2000; 128: 1043–1050.
18.
McKayJD, LesueurF, JonardL. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet.2001; 69: 440–446.
19.
BurgessJR, DuffieldA, WilkinsonSJ. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab.1997; 82: 345–348.
20.
LepratF, BonichonF, GuyotM. Familial nonmedullary thyroid carcinoma: pathology review in 27 affected cases from 13 French families. Clin Endocrinol (Oxf).1999; 50: 589–594.
21.
LupoliG, VitaleG, CaragliaM. Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet.1999; 353: 637–639.
MáximoV, BotelhoT, CapelaJ. Somatic and germline mutation in GRIM-19, a dual function gene involved in mito-chondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer.2005; 92: 1892–1898.
24.
HarachHR, LesueurF, AmatiP. Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2. J Pathol.1999; 189: 387–393.
25.
KraimpsJL, CanzianF, JostC. Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene. Surgery.1999; 126: 1188–1194.
26.
MalchoffCD, SarfaraziM, TendlerB. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab.2000; 85: 1758–1764.
27.
BignellGR, CanzianF, ShayeghiM. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet.1997; 61: 1123–1130.
28.
CaponF, TacconelliA, GiardinaE. Mapping a dominant form of multinodular goiter to chromosome Xp22. Am J Hum Genet.2000; 67: 1004–1007.
29.
BrunaudL, ZarnegarR, WadaN. Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer. Thyroid.2003; 13: 621–629.
30.
CavacoBM, BatistaPF, MartinsC. Familial nonmedullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocr Relat Cancer.2008; 15: 207–215.
31.
Cameselle-TeijeiroJ, MenasceLP, YapBK. Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior. Am J Clin Pathol.2009; 131: 134–142.
32.
HarachHR, WilliamsGT, WilliamsED. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology.1994; 25: 549–561.
33.
Cameselle-TeijeiroJ, AbdulkaderI, SoaresP, Romero-RojasA, Reyes-SantíasRM, Sobrinho-SimõesM. Cribriform-morular variant of papillary thyroid carcinoma. A prototype of clinical, pathological and genetic correlation. Hot Thyroidology. 2009, http://www.hotthyroidology.com/recent_articles.php/HT10/09.
34.
PilarskiR. Cowden syndrome: a critical review of the clinical literature. J Genet Couns.2009; 18: 13–27.
35.
HarachHR, SoubeyranI, BrownA, BonneauD, LongyM. Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol.1999; 3: 331–340.
36.
KameyamaK, TakamiH, MiyajimaK. Papillary carcinoma occurring within an adenomatous goiter of the thyroid gland in Cowden's disease. Endocr Pathol.2001; 12: 73–76.
37.
ZambranoE, HolmI, GlickmanJ. Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated tumor syndromes. Endocr Pathol.2004; 15: 55–64.
38.
ZbukKM, PatocsA, ShealyA, SylvesterH, MiesfeldtS, EngC. Germline mutations in PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paraganglioma. Nat Clin Pract Oncol.2007; 4: 608–612.
39.
BertheratJ, HorvathA, GroussinL. Mutations in regulatory subunit type 1A of cyclic adenosine 5,-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab.2009; 94: 2085–2091.
40.
StratakisCA, CourcoutsakisNA, AbatiA. Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab.1997; 82: 2037–2043.
41.
StratakisCA, KirschnerLS, TaymansSE. Carney complex, Peutz-Jeghers syndrome, Cowden disease, and Bannayan-Zonana syndrome share cutaneous and endocrine manifestations, but not genetic loci. J Clin Endocrinol Metab.1998; 83: 2972–2976.
42.
GotoM, MillerRW, IshikawaY, SuganoH. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev.1996; 5: 239–246.
43.
IshikawaY, SuganoH, MatsumotoT, FuruichiY, MillerRW, GotoM. Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer.1999; 85: 1345–1352.
44.
MonnatRJJr. Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible gen-otype-phenotype relations to cell type and race. Cancer.1999; 86: 728–729.
45.
VortmeyerAO, LubenskyIA, SkarulisM. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors. Mod Pathol.1999; 12: 919–924.
46.
DesaiD, McPhersonLA, HigginsJP, WeigelRJ. Genetic analysis of a papillary thyroid carcinoma in a patient with MEN1. Ann Surg Oncol.2001; 8: 342–346.
47.
SakaiY, KoizumiK, SugitaniI. Familial adenomatous polyposis associated with multiple endocrine neoplasia type 1-related tumors and thyroid carcinoma: a case report with clinicopathologic and molecular analyses. Am J Surg Pathol.2002; 26: 103–110.
48.
HarachHR. Familial adenomatous polyposis associated with sporadic MEN 1 and thyroid carcinoma related to APC mutation. Am J Surg Pathol.2003; 27: 412–413.
49.
KimHJ, ParkJS, KimCS. A case of multiple endocrine neoplasia type 1 combined with papillary thyroid carcinoma. Yonsei Med J.2008; 49: 503–506.
50.
LofflerKA, BiondiCA, GartsideM. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. Int J Cancer.2007; 120: 259–267.
51.
GiacomelliL, GuerrieroG, FalvoL. Simultaneous occurrence of medullary carcinoma and papillary microcarcinoma of thyroid in a patient with MEN 2A syndrome. Report of a case. Tumori.2007; 93: 109–111.
52.
MelilloRM, CiraficiAM, De FalcoV. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Am J Pathol.2004; 165: 511–521.
53.
BiscollaRP, UgoliniC, SculliM. Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior. Thyroid.2004; 14: 946–952.
54.
ShifrinAL, XenachisC, FayA, MatulewiczTJ, KuoYH, VernickJJ. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: Is this a new syndrome-MEN 2C?Surgery.2009; 146: 998–1005.
55.
CollinsMT, SarlisNJ, MerinoMJ. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab.2003; 88: 4413–4417.
56.
TalbotIC, BurtR, JärvinenH. Familial adenomatous polyposis. In: HamiltonSR, AaltonenLA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System.Lyon, France: IARC Press;2000: 120–125.
57.
HerraizM, BarbesinoG, FaquinW. Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol.2007; 5: 367–373.
58.
Cameselle-TeijeiroJ, ChanJK. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-asso-ciated thyroid carcinoma?Mod Pathol.1999; 12: 400–411.
59.
Cameselle-TeijeiroJ, Alberte-ListaL, ChiarelliS. CD10 is a characteristic marker of tumours forming morules with biotin-rich, optically clear nuclei that occur in different organs. Histopathology.2008; 52: 389–392.
60.
JungCK, ChoiYJ, LeeKY. The cytological, clinical, and pathological features of the cribriform-morular variant of papillary thyroid carcinoma and mutation analysis of CTNNB1 and BRAF genes. Thyroid.2009; 19: 905–913.
61.
CettaF, MontaltoG, GoriM, CuriaMC, CamaA, OlschwangS. Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma:results from a European cooperative study. J Clin Endocrinol Metab.2000; 85: 286–292.
62.
Cameselle-TeijeiroJ, Ruiz-PonteC, LoidiL, Suarez-PeñarandaJ, BaltarJ, Sobrinho-SimõesM. Somatic but not germline mutation of the APC gene in a case of cribriform-morular variant of papillary thyroid carcinoma. Am J Clin Pathol.2001; 115: 486–493.
63.
XuB, YoshimotoK, MiyauchiA. Cribriformmorular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. J Pathol.2003; 199: 58–67.
64.
SchuetzeD, HoscharAP, SeethalaRR, AssaadA, ZhangX, HuntJL. The T1799A BRAF mutation is absent in cribriform-morular variant of papillary carcinoma. Arch Pathol Lab Med.2009; 133: 803–805.
65.
NiY, ZbukKM, SadlerT. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet.2008; 83: 261–268.
66.
CourcoutsakisN, PatronasN, FilieAC, CarneyJA, MoraitisA, StratakisCA. Ectopic thymus presenting as a thyroid nodule in a patient with the Carney complex. Thyroid.2009; 19: 293–296.
67.
CongedoV, CeliFS. Thyroid disease in patients with McCune-Albright syndrome. Pediatr Endocrinol Rev.2007; 4(Suppl 4): 429–433.